111 Price to Book Ratio 2018-2024 | YI

Historical price to book ratio values for 111 (YI) over the last 10 years. The current price to book ratio for 111 as of November 20, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

111 Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-11-19 0.62 inf
2024-06-30 1.07 0.00
2024-03-31 1.16 0.00
2023-12-31 1.55 $-0.98 -1.58
2023-09-30 2.60 0.00
2023-06-30 2.46 0.00
2023-03-31 2.65 0.00
2022-12-31 3.02 $-0.71 -4.26
2022-09-30 2.68 0.00
2022-06-30 2.06 0.00
2022-03-31 2.66 0.00
2021-12-31 3.50 $-0.29 -12.18
2021-09-30 6.17 0.00
2021-06-30 9.09 0.00
2021-03-31 13.80 0.00
2020-12-31 6.95 $0.75 9.23
2020-09-30 6.20 0.00
2019-09-30 4.87 $1.60 3.04
2019-06-30 5.56 $3.31 1.68
2019-03-31 6.49 $3.58 1.81
2018-09-30 13.52 $4.27 3.17
2019-12-31 6.73 $1.35 4.97
2020-06-30 6.35 0.00
2020-03-31 6.61 $1.15 5.76
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.053B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Inspire Medical Systems (INSP) United States $5.276B 164.53
Hims & Hers Health (HIMS) United States $5.141B 130.72
Privia Health (PRVA) United States $2.533B 211.10
Enovis (ENOV) United States $2.529B 17.15
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00